BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients


4/3/2009 12:10:41 PM

Lexington, Mass., April 3, 2009 – Microbia, Inc. (Microbia), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, has appointed Mike Doyle to the newly created position of senior vice president and general manager of nutrition ingredients. Mr. Doyle will have broad responsibility for all aspects of Microbia’s nutrition ingredients business, including strategic planning, marketing, sales, operations, supply chain management and strategic partnerships in preparation for the launch of Microbia’s line of naturally derived carotenoids for the food ingredient and nutritional supplement markets.

“Microbia’s goal is to utilize our proprietary, bio-based technology platform to produce nutritional ingredients that will help the food and feed industries make products more innovative, cost-effective and environmentally sustainable,” said Richard Bailey, Ph.D., CEO of Microbia. “Mike Doyle has the experience, energy and skills required to lead this effort, and holds a track record of success managing relevant nutrition businesses. We look forward to drawing on his substantial expertise to establish a strong position in the nutrition ingredients marketplace.”

“I am eager to help Microbia bring the vast promise of its exciting technology to market,” said Mr. Doyle. “Microbia has a significant competitive position based on its advanced metabolic engineering innovations. Our goal is to become a leading global supplier of nutrition ingredients that deliver significant added value to our customers in the feed, food, beverage, and dietary supplement industries.”

Mike Doyle brings more than 12 years of executive management experience to Microbia, including as director, human nutrition for BASF’s North American business, and most recently, as president of LycoRed, Corp. in North America. While at BASF, Mr. Doyle oversaw development and marketing of vitamins, carotenoids, food and beverage polymers, and other food ingredients. At LycoRed Corp., Mr. Doyle was responsible for all operations in the North American marketplace. Mr. Doyle is also a former board member and Treasurer of the Council for Responsible Nutrition. He received a B.S. degree in marketing and industrial management from New York University, and an M.B.A. from Michigan State University.

ABOUT MICROBIA (WWW.MICROBIA-PE.COM)

Microbia is an industrial biotechnology company applying proprietary metabolic engineering to create cost-effective, renewable specialty ingredients and biomaterials. Microbia will develop and commercialize its products through direct sales and strategic alliances, including an ongoing multi-product joint development and commercialization agreement with Tate & Lyle Investments, Ltd. Microbia’s carotenoids will be the first products launched from a diverse pipeline of specialty ingredients, biopolymers and other biomaterials. Microbia was established in 2006 as a majority-owned subsidiary of Ironwood Pharmaceuticals, Inc. and is based in Lexington, Massachusetts.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES